So-Young Yeo

666 total citations
12 papers, 497 citations indexed

About

So-Young Yeo is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, So-Young Yeo has authored 12 papers receiving a total of 497 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 8 papers in Oncology and 3 papers in Cancer Research. Recurrent topics in So-Young Yeo's work include Cancer Cells and Metastasis (6 papers), Fibroblast Growth Factor Research (3 papers) and Epigenetics and DNA Methylation (3 papers). So-Young Yeo is often cited by papers focused on Cancer Cells and Metastasis (6 papers), Fibroblast Growth Factor Research (3 papers) and Epigenetics and DNA Methylation (3 papers). So-Young Yeo collaborates with scholars based in South Korea and China. So-Young Yeo's co-authors include Seok‐Hyung Kim, Chang Ohk Sung, Sang Yun Ha, Keun‐Woo Lee, Kwang‐Hyun Cho, Dongkwan Shin, Yong Beom Cho, Yanhua Xuan, Zhaoting Yang and Yan Cui and has published in prestigious journals such as Nature Communications, PLoS ONE and Cancer Research.

In The Last Decade

So-Young Yeo

12 papers receiving 493 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
So-Young Yeo South Korea 9 280 259 116 80 60 12 497
Leili Saeednejad Zanjani Iran 13 273 1.0× 201 0.8× 114 1.0× 74 0.9× 75 1.3× 37 497
Anke Van den broeck Belgium 6 233 0.8× 285 1.1× 128 1.1× 53 0.7× 37 0.6× 9 433
Roxane M. Pommier France 11 224 0.8× 149 0.6× 107 0.9× 73 0.9× 52 0.9× 19 443
Yumi Kinugasa Japan 9 273 1.0× 254 1.0× 106 0.9× 65 0.8× 65 1.1× 10 472
Takahiro Heishi Japan 10 298 1.1× 206 0.8× 118 1.0× 188 2.4× 39 0.7× 16 586
Zhaoting Yang China 17 382 1.4× 304 1.2× 182 1.6× 88 1.1× 69 1.1× 26 647
Charlotte Anderberg Sweden 5 288 1.0× 195 0.8× 136 1.2× 40 0.5× 39 0.7× 7 446
Sander P.J. Joosten Netherlands 10 288 1.0× 236 0.9× 101 0.9× 53 0.7× 95 1.6× 12 481
Samantha McGee United States 7 229 0.8× 337 1.3× 147 1.3× 141 1.8× 36 0.6× 8 628
Jahedul Alam Norway 7 193 0.7× 156 0.6× 119 1.0× 60 0.8× 65 1.1× 8 406

Countries citing papers authored by So-Young Yeo

Since Specialization
Citations

This map shows the geographic impact of So-Young Yeo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by So-Young Yeo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites So-Young Yeo more than expected).

Fields of papers citing papers by So-Young Yeo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by So-Young Yeo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by So-Young Yeo. The network helps show where So-Young Yeo may publish in the future.

Co-authorship network of co-authors of So-Young Yeo

This figure shows the co-authorship network connecting the top 25 collaborators of So-Young Yeo. A scholar is included among the top collaborators of So-Young Yeo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with So-Young Yeo. So-Young Yeo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Yeo, So-Young, Ok Jae Koo, Insuk Sohn, et al.. (2022). PRRX1 is a master transcription factor of stromal fibroblasts for myofibroblastic lineage progression. Nature Communications. 13(1). 2793–2793. 56 indexed citations
2.
Choi, Sangjoon, Keun‐Woo Lee, Sujin Park, et al.. (2021). Validation of ZMYND8 as a new treatment target in hepatocellular carcinoma. Journal of Cancer Research and Clinical Oncology. 147(12). 3517–3534. 4 indexed citations
3.
Ha, Sang Yun, So-Young Yeo, Keun‐Woo Lee, & Seok Hyung Kim. (2020). Validation of ORAOV1 as a new treatment target in hepatocellular carcinoma. Journal of Cancer Research and Clinical Oncology. 147(2). 423–433. 1 indexed citations
4.
Yeo, So-Young, et al.. (2020). New screening system using Twist1 promoter activity identifies dihydrorotenone as a potent drug targeting cancer-associated fibroblasts. Scientific Reports. 10(1). 7058–7058. 5 indexed citations
5.
Yun, Sun‐Il, Hye Kyung Hong, So-Young Yeo, et al.. (2020). Ubiquitin-Specific Protease 21 Promotes Colorectal Cancer Metastasis by Acting as a Fra-1 Deubiquitinase. Cancers. 12(1). 207–207. 36 indexed citations
6.
Lee, Hakmin, So-Young Yeo, Sang Hyun Shin, et al.. (2018). Drug repurposing screening identifies bortezomib and panobinostat as drugs targeting cancer associated fibroblasts (CAFs) by synergistic induction of apoptosis. Investigational New Drugs. 36(4). 545–560. 14 indexed citations
7.
Yeo, So-Young, et al.. (2018). A positive feedback loop bi-stably activates fibroblasts. Nature Communications. 9(1). 3016–3016. 82 indexed citations
8.
Yeo, So-Young, Keun‐Woo Lee, Yan Cui, et al.. (2017). Twist1 is highly expressed in cancer-associated fibroblasts of esophageal squamous cell carcinoma with a prognostic significance. Oncotarget. 8(39). 65265–65280. 23 indexed citations
9.
Yang, Zhaoting, So-Young Yeo, Zhenhua Lin, et al.. (2016). Tenascin-C, a Prognostic Determinant of Esophageal Squamous Cell Carcinoma. PLoS ONE. 11(1). e0145807–e0145807. 50 indexed citations
10.
Yeo, So-Young, et al.. (2014). Twist1 Is a Key Regulator of Cancer-Associated Fibroblasts. Cancer Research. 75(1). 73–85. 116 indexed citations
11.
Ha, Sang Yun, et al.. (2014). The Prognostic Significance of Cancer-Associated Fibroblasts in Esophageal Squamous Cell Carcinoma. PLoS ONE. 9(6). e99955–e99955. 99 indexed citations
12.
Yeo, So-Young, et al.. (2014). ZNF282 (Zinc finger protein 282), a novel E2F1 co-activator, promotes esophageal squamous cell carcinoma. Oncotarget. 5(23). 12260–12272. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Leili Saeednejad Zanjani Breakdown of academic impact, for papers by Anke Van den broeck Breakdown of academic impact, for papers by Roxane M. Pommier Breakdown of academic impact, for papers by Yumi Kinugasa Breakdown of academic impact, for papers by Takahiro Heishi Breakdown of academic impact, for papers by Zhaoting Yang Breakdown of academic impact, for papers by Charlotte Anderberg Breakdown of academic impact, for papers by Sander P.J. Joosten Breakdown of academic impact, for papers by Samantha McGee Breakdown of academic impact, for papers by Jahedul Alam
Rankless by CCL
2026